Immunoengineering: An Emerging Field in Infectious Diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40259762.
- Also identified by DOI 10.1093/infdis/jiaf209 and PMC identifier 12308683.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As the disciplines of materials science, bioengineering, and immunology mature in the 21st century, the convergence science of immunoengineering has emerged as a paradigm to augment host immunity. By delivering biochemical and mechanical cues with engineered precision, the immune system can be stimulated to respond to specific antigens with a designed phenotype. While cancer has driven the early discoveries in immunoengineering, the field of infectious diseases stands to benefit tremendously by applying the concepts of immunoengineering to current clinical challenges. Antimicrobial resistance, highly communicable emerging pathogens, and infections in immunocompromised hosts are some examples of current problems that are suitable for immunoengineering approaches. Here, we will introduce basic concepts associated with immunoengineering and provide current examples applied to infectious diseases, including cell therapies, immunomodulating small molecule delivery, and next-generation vaccine development with implantable biomaterials.
Medical subject headings
- Communicable Diseases
- Bioengineering